The Characterization of Microtubule-Stabilizing Drugs as Possible Therapeutic Agents for Alzheimer's Disease and Related Tauopathies

Pharmacological Research- United States

doi 10.1016/j.phrs.2010.12.002

Full Text

Abstract

Available in

Categories

Pharmacology

Date

Authors

Publisher

Elsevier BV

Related search

Characterization of Brain-Penetrant Pyrimidine-Containing Molecules With Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimers Disease and Related Tauopathies

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2016English

Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer's Disease

Molecular Pharmacology
Molecular MedicinePharmacology
2019English

Platinum-Based Inhibitors of Amyloid- As Therapeutic Agents for Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2014English

High-Contrast In-Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies

2020English

Bugs as Drugs: Therapeutic Microbes for the Prevention and Treatment of Disease

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2019English

Vaccination as a Therapeutic Approach to Alzheimer's Disease

Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
2010English

Tau-Induced Neurodegeneration in Alzheimer Disease and Related Tauopathies

2013English

Repursposing the Kca3.1 Blocker Senicapoc as a Microglia-Targeted Therapeutic for Alzheimer's Disease

Biophysical Journal
Biophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy